BRC News

Initial treatment for HIV is three times more likely to fail if a person is infected with transmitted drug resistant (TDR) HIV compared to non-resistant HIV, according to a European-wide study involving CBRC and UCL investigators.

CBRC investigator Professor Derek Yellon is one of 23 eminent researchers to be honoured with the status of National Institute of Health Research (NIHR) Senior Investigator in the latest round of NIHR appointments.

CBRC-supported research has developed the world’s first accurate blood test for variant Creutzfeldt-Jakob disease (vCJD).

In a unique collaboration, medical research scientists from across London have joined forces to establish a comprehensive biomedical research faculty.

We are holding a series of seminars on 7 March to showcase the best of activities. This is in support of the development of a new Bloomsbury Institute of Pathogen Research which is nearing completion.

Simply looking at your body cuts down the pain you feel, according to new research supported by the CBRC.